Australia & New Zealand Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Country, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Augmented Analytics Market Growth & Trends
The global augmented analytics market size is expected to reach USD 97.87 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 28.0% from 2024 to 2030.
Data has become one of the most critical assets for any organization. Every organization’s progress depends on how correctly the data resources are being used. To ensure that data resources are appropriately used, enterprises are depending on data scientists, which are rare resources, to get actionable insights. This has driven the adoption of augmented analytics among organizations, which eliminates the dependency on data scientists. The augmented analytics technology allows enterprises to get consistent data with fewer errors in lesser time. It also accelerates data preparation and discovery with the help of advanced tools such as machine learning and artificial intelligence. In addition, it eliminates the requirement of any technical person to write algorithms for creating data analysis models that can determine insights.
The field of data analytics has evolved significantly in recent years. The increasing requirement of data scientists to analyze massive volumes of data to derive actionable insights has generated the need for augmented analytics. The technology automates the data science steps and analysis used in the process of advanced analytics, thereby providing actionable insights from data. This is done by using linguistic and statistical technologies to break down big data into small chunks that are more usable.
The augmented analytics technology has helped in delivering more detailed and relevant insights from the copious amount of data stored within an organization or generated during everyday operations and procedures. Factors such as rising demand of intelligent business tools in the field of data analytics, increasing adoption of smart discovery tools for business users, rising need for an increase in productivity, and the growing adoption of technology across diversified industry verticals are propelling the growth of the augmented analytics market.
Augmented Analytics Market Report Highlights
Augmented Analytics Market Growth & Trends
The global augmented analytics market size is expected to reach USD 97.87 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 28.0% from 2024 to 2030.
Data has become one of the most critical assets for any organization. Every organization’s progress depends on how correctly the data resources are being used. To ensure that data resources are appropriately used, enterprises are depending on data scientists, which are rare resources, to get actionable insights. This has driven the adoption of augmented analytics among organizations, which eliminates the dependency on data scientists. The augmented analytics technology allows enterprises to get consistent data with fewer errors in lesser time. It also accelerates data preparation and discovery with the help of advanced tools such as machine learning and artificial intelligence. In addition, it eliminates the requirement of any technical person to write algorithms for creating data analysis models that can determine insights.
The field of data analytics has evolved significantly in recent years. The increasing requirement of data scientists to analyze massive volumes of data to derive actionable insights has generated the need for augmented analytics. The technology automates the data science steps and analysis used in the process of advanced analytics, thereby providing actionable insights from data. This is done by using linguistic and statistical technologies to break down big data into small chunks that are more usable.
The augmented analytics technology has helped in delivering more detailed and relevant insights from the copious amount of data stored within an organization or generated during everyday operations and procedures. Factors such as rising demand of intelligent business tools in the field of data analytics, increasing adoption of smart discovery tools for business users, rising need for an increase in productivity, and the growing adoption of technology across diversified industry verticals are propelling the growth of the augmented analytics market.
Augmented Analytics Market Report Highlights
- Increasing adoption of predictive and prescriptive analytics to determine the information and appropriate reasoning for any analysis coupled with the growing need for data quality management to clean and prepare data and distribute it across the enterprise will spur the growth of the market
- The adoption of cloud-based analytics is expected to increase due to capabilities such as agility and quick response time along with robustness offered by the cloud
- The integration of artificial intelligence and automation into augmented analytics technology is augmenting the user experience by providing capabilities such as chatbots to enable real-time services to customers
- The North American region dominated the augmented analytics market in 2023. The Asia Pacific region is projected to register the highest CAGR from 2024 to 2030
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Australia & New Zealand Research Antibodies Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Australia & New Zealand Research Antibodies Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Primary
4.3.1. Primary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Secondary
4.4.1. Secondary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: SPECIFICITY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Australia & New Zealand Research Antibodies Market: Specificity Movement Analysis, USD Million, 2023 & 2030
5.3. Monoclonal Antibodies
5.3.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Polyclonal Antibodies
5.4.1. Polyclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Australia & New Zealand Research Antibodies Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Immunohistochemistry
6.3.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Immunofluorescence
6.4.1. Immunofluorescence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Western blotting
6.5.1. Western blotting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Flow cytometry
6.6.1. Flow cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Immunoprecipitation
6.7.1. Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. ELISA
6.8.1. ELISA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: SOURCE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Australia & New Zealand Research Antibodies Market: Source Movement Analysis, USD Million, 2023 & 2030
7.3. Mice
7.3.1. Mice Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Rabbit
7.4.1. Rabbit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Goat
7.5.1. Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Others
7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Australia & New Zealand Research Antibodies Market: Application Movement Analysis, USD Million, 2023 & 2030
8.3. Infectious Diseases
8.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Immunology
8.4.1. Immunology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Oncology
8.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Stem Cells
8.6.1. Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Neurobiology
8.7.1. Neurobiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Others
8.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: END-USE ESTIMATES & TREND ANALYSIS
9.1. Segment Dashboard
9.2. Australia & New Zealand Research Antibodies Market: End-use Movement Analysis, USD Million, 2023 & 2030
9.3. Hospitals
9.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Non-Hospitals
9.4.1. Non-Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
10.1. Australia & New Zealand Research Antibodies Market Share, By Country, 2023 & 2030, USD Million
10.2. Australia
10.2.1. Australia Research Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.3. New Zealand
10.3.1. New Zealand Research Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 11. COMPETITIVE LANDSCAPE
11.1. Recent Developments & Impact Analysis by Key Market Participants
11.2. Company Categorization
11.3. Company Heat Map Analysis
11.4. Company Profiles
11.4.1. Abcam Limited
11.4.1.1. Participant’s Overview
11.4.1.2. Financial Performance
11.4.1.3. Product Benchmarking
11.4.1.4. Recent Developments/ Strategic Initiatives
11.4.2. Bio-Rad Laboratories, Inc.
11.4.2.1. Participant’s Overview
11.4.2.2. Financial Performance
11.4.2.3. Product Benchmarking
11.4.2.4. Recent Developments/ Strategic Initiatives
11.4.3. BD
11.4.3.1. Participant’s Overview
11.4.3.2. Financial Performance
11.4.3.3. Product Benchmarking
11.4.3.4. Recent Developments/ Strategic Initiatives
11.4.4. Merck KGaA
11.4.4.1. Participant’s Overview
11.4.4.2. Financial Performance
11.4.4.3. Product Benchmarking
11.4.4.4. Recent Developments/ Strategic Initiatives
11.4.5. Lonza
11.4.5.1. Participant’s Overview
11.4.5.2. Financial Performance
11.4.5.3. Product Benchmarking
11.4.5.4. Recent Developments/ Strategic Initiatives
11.4.6. Thermo Fisher Scientific Inc.
11.4.6.1. Participant’s Overview
11.4.6.2. Financial Performance
11.4.6.3. Product Benchmarking
11.4.6.4. Recent Developments/ Strategic Initiatives
11.4.7. Cell Signaling Technology, Inc.
11.4.7.1. Participant’s Overview
11.4.7.2. Financial Performance
11.4.7.3. Product Benchmarking
11.4.7.4. Recent Developments/ Strategic Initiatives
11.4.8. F. Hoffmann-La Roche Ltd.
11.4.8.1. Participant’s Overview
11.4.8.2. Financial Performance
11.4.8.3. Product Benchmarking
11.4.8.4. Recent Developments/ Strategic Initiatives
11.4.9. Agilent Technologies, Inc.
11.4.9.1. Participant’s Overview
11.4.9.2. Financial Performance
11.4.9.3. Product Benchmarking
11.4.9.4. Recent Developments/ Strategic Initiatives
11.4.10. Revvity
11.4.10.1. Participant’s Overview
11.4.10.2. Financial Performance
11.4.10.3. Product Benchmarking
11.4.10.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Australia & New Zealand Research Antibodies Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Australia & New Zealand Research Antibodies Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Primary
4.3.1. Primary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Secondary
4.4.1. Secondary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: SPECIFICITY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Australia & New Zealand Research Antibodies Market: Specificity Movement Analysis, USD Million, 2023 & 2030
5.3. Monoclonal Antibodies
5.3.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Polyclonal Antibodies
5.4.1. Polyclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Australia & New Zealand Research Antibodies Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Immunohistochemistry
6.3.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Immunofluorescence
6.4.1. Immunofluorescence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Western blotting
6.5.1. Western blotting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Flow cytometry
6.6.1. Flow cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Immunoprecipitation
6.7.1. Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. ELISA
6.8.1. ELISA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: SOURCE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Australia & New Zealand Research Antibodies Market: Source Movement Analysis, USD Million, 2023 & 2030
7.3. Mice
7.3.1. Mice Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Rabbit
7.4.1. Rabbit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Goat
7.5.1. Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Others
7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Australia & New Zealand Research Antibodies Market: Application Movement Analysis, USD Million, 2023 & 2030
8.3. Infectious Diseases
8.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Immunology
8.4.1. Immunology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Oncology
8.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Stem Cells
8.6.1. Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Neurobiology
8.7.1. Neurobiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Others
8.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: END-USE ESTIMATES & TREND ANALYSIS
9.1. Segment Dashboard
9.2. Australia & New Zealand Research Antibodies Market: End-use Movement Analysis, USD Million, 2023 & 2030
9.3. Hospitals
9.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Non-Hospitals
9.4.1. Non-Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. AUSTRALIA & NEW ZEALAND RESEARCH ANTIBODIES MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
10.1. Australia & New Zealand Research Antibodies Market Share, By Country, 2023 & 2030, USD Million
10.2. Australia
10.2.1. Australia Research Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.3. New Zealand
10.3.1. New Zealand Research Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 11. COMPETITIVE LANDSCAPE
11.1. Recent Developments & Impact Analysis by Key Market Participants
11.2. Company Categorization
11.3. Company Heat Map Analysis
11.4. Company Profiles
11.4.1. Abcam Limited
11.4.1.1. Participant’s Overview
11.4.1.2. Financial Performance
11.4.1.3. Product Benchmarking
11.4.1.4. Recent Developments/ Strategic Initiatives
11.4.2. Bio-Rad Laboratories, Inc.
11.4.2.1. Participant’s Overview
11.4.2.2. Financial Performance
11.4.2.3. Product Benchmarking
11.4.2.4. Recent Developments/ Strategic Initiatives
11.4.3. BD
11.4.3.1. Participant’s Overview
11.4.3.2. Financial Performance
11.4.3.3. Product Benchmarking
11.4.3.4. Recent Developments/ Strategic Initiatives
11.4.4. Merck KGaA
11.4.4.1. Participant’s Overview
11.4.4.2. Financial Performance
11.4.4.3. Product Benchmarking
11.4.4.4. Recent Developments/ Strategic Initiatives
11.4.5. Lonza
11.4.5.1. Participant’s Overview
11.4.5.2. Financial Performance
11.4.5.3. Product Benchmarking
11.4.5.4. Recent Developments/ Strategic Initiatives
11.4.6. Thermo Fisher Scientific Inc.
11.4.6.1. Participant’s Overview
11.4.6.2. Financial Performance
11.4.6.3. Product Benchmarking
11.4.6.4. Recent Developments/ Strategic Initiatives
11.4.7. Cell Signaling Technology, Inc.
11.4.7.1. Participant’s Overview
11.4.7.2. Financial Performance
11.4.7.3. Product Benchmarking
11.4.7.4. Recent Developments/ Strategic Initiatives
11.4.8. F. Hoffmann-La Roche Ltd.
11.4.8.1. Participant’s Overview
11.4.8.2. Financial Performance
11.4.8.3. Product Benchmarking
11.4.8.4. Recent Developments/ Strategic Initiatives
11.4.9. Agilent Technologies, Inc.
11.4.9.1. Participant’s Overview
11.4.9.2. Financial Performance
11.4.9.3. Product Benchmarking
11.4.9.4. Recent Developments/ Strategic Initiatives
11.4.10. Revvity
11.4.10.1. Participant’s Overview
11.4.10.2. Financial Performance
11.4.10.3. Product Benchmarking
11.4.10.4. Recent Developments/ Strategic Initiatives
